Limited Competition: Cancer Immunotherapy Trials Network (CITN)(UM1)
ID: RFA-CA-16-501 • Type: Posted
Opportunity Assistant
Loading
Overview
Category of Funding
Education
Health
Health
Funding Instruments
Cooperative Agreement
Grant Program (CFDA)
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 11/25/16 the National Institutes of Health posted grant opportunity RFA-CA-16-501 for Limited Competition: Cancer Immunotherapy Trials Network (CITN)(UM1) with funding of $4.0 million.
The grant will be issued under grant program 93.395 Cancer Treatment Research.
Timing
Posted Date
Nov. 25, 2016, 12:00 a.m. EST
Closing Date
March 10, 2017, 12:00 a.m. EST Past Due
Last Updated
Jan. 27, 2017, 1:21 p.m. EST
Version
3
Archive Date
April 9, 2017
Eligibility
Eligible Applicants
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Private institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Private institutions of higher education
Additional Info
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. Only the current awardee of CITN COSC is eligible to apply. See FOA for eligibility details
Award Sizing
Ceiling
$3,000,000
Floor
Not Listed
Estimated Program Funding
$4,000,000
Estimated Number of Grants
Not Listed
Contacts
Contact Email
Email Description
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Additional Information Site